CRSPThe Clinical Research Scholars Program (CRSP) is an intensive mentored research career development program. The objective of the CRSP is to support the development of successful clinical, translational and outcomes researchers among junior faculty affiliated with Seattle Children's. This goal is accomplished through a structured program of financial support, educational seminars and mentoring by dedicated CRSP faculty.

The CRSP supports career development in a wide range of research areas, including the mechanisms and treatment of diseases of children, as well as research related to areas such as patient safety and quality improvement.

The program is administered by Program Director Dr. Margaret Rosenfeld, Associate Program Director Dr. Joseph Flynn and the Center for Clinical and Translational Research (CCTR) Business Office. The program is being piloted for two years in the CCTR with the intention to ultimately become a Seattle Children's Research Institute-wide initiative.

Eligibility Criteria

  • Rank of acting instructor, acting assistant professor or assistant professor
  • Member of the CCTR. Future grant applications must be submitted through CCTR.
  • Standard path: Seattle Children’s based clinician-educator or clinician-clinician track *
  • Intensive path: Seattle Children’s based junior faculty, generally in physician-scientist track
  • Applicant’s division chief must guarantee:
    • Standard: Minimum 20% FTE (10% from CCTR, balance from division/department)
    • Intensive: Minimum 50% FTE (25% from CCTR, balance from division/department)
     
  • A primary mentor must be identified, with willingness to mentor demonstrated in a letter of support.
  • The applicant should propose career development in clinical, translational or outcomes research that includes enrollment of human subjects.
  • International projects will not be funded at this time.

* Faculty in clinician-clinician path may apply only if clear documentation by division chief of expectation and protected time for research.

Path Details

Standard Path

The standard path is designed for Scholars with limited protected time and background in clinical research. A primary objective of the program is to mentor the Scholar in the preparation of a successful application for intramural or pilot project grants. 

The standard path requires a minimum of 20% protected research effort. The CCTR provides salary support for 10% effort for two years, not to exceed $18,000 per year. The Scholar’s division/department provides support for the balance of the protected time. In addition, the CCTR awards research support funds up to $10,000 annually to each Scholar for career or project development.

At the completion of the program, Scholars are expected to have 1) submitted abstracts and at least one manuscript; 2) presented at local or national meetings; 3) have grant funding as a principal investigator on a pilot or internal award or as a co-investigator on an extramural award. 

Intensive Path

The intensive path is designed for Scholars with substantial protected research time and background in clinical, translational or outcomes research. Applicants must enter the program with a well-defined research proposal. 

The intensive pathway requires a minimum of 50% protected research effort. The CCTR will pay up to 25% of the Scholar’s salary for two years, not to exceed $25,000 per year. The Scholar’s division/department must provide support for the balance of the protected effort. In addition, the CCTR awards up to $20,000 annually to each Scholar for tuition and/or pilot funding for a research project.

At the completion of the program, Scholars are expected to have 1) submitted abstracts and manuscripts, 2) presented at national meetings, and 3) to have successfully applied for a K-series or equivalent career development award.

See the CRSP Program Overview (PDF) for full details. 

Key Dates

  • RFA Released: January 4, 2016
  • Application Deadline: April 15, 2016 
  • Award Announcement: June 2016 
  • IRB Approved and First Mentor Meeting Completed: Sept 30, 2016
  • Funding Begins: October 1, 2016